• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测上尿路上皮癌不良病理结局的因素:来自中国一个全国性大容量中心的经验。

Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.

机构信息

Department of Urology, Peking University First Hospital, Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.

出版信息

BJU Int. 2013 Nov;112(7):917-24. doi: 10.1111/bju.12238. Epub 2013 Jul 26.

DOI:10.1111/bju.12238
PMID:23905945
Abstract

OBJECTIVES

To analyse the predictive factors for worse pathological outcome (muscle invasive pT2+, non-organ-confined pT3+ or N+ and histological Grade 3) of upper tract urothelial carcinoma (UTUC) in a Chinese population from a nationwide high-volume centre in China.

PATIENTS AND METHODS

Predictors were studied by retrospectively reviewing the clinicopathological data of 729 consecutive patients with UTUC treated in our centre from January 2002 to December 2010. Univariate and multivariate logistic regression analyses were used.

RESULTS

There were more female patients (56.4%) than males and more tumours were located in the ureter (52.7%) than in the pelvis. In multivariate analysis, male gender (hazard ratio [HR] 1.898, P = 0.001), sessile architecture (HR 3.249, P < 0.001), high grade (HR 5.007, P < 0.001), ipsilateral hydronephrosis (HR 4.768, P < 0.001), renal pelvis location (HR 2.620, P < 0.001) and tumour without multifocality (HR 1.639, P = 0.028) were predictive factors for muscle-invasive UTUC. Male gender (HR 2.132, P < 0.001), renal pelvis location (HR 3.466, P < 0.001), tumour without multifocality (HR 2.532, P = 0.001), sessile tumour architecture (HR 3.274, P < 0.001), and high grade (HR 3.019, P < 0.001) were predictive factors for non-organ-confined disease. Chronological old age (HR 1.047, P < 0.001), sessile tumour architecture (HR 25.192, P < 0.001), ipsilateral hydronephrosis (HR 1.689, P = 0.024), and positive urinary cytology (HR 1.997, P = 0.006) were predictive factors for histological Grade 3 UTUC.

CONCLUSIONS

There was a predominance of female patients and ureteric tumours in UTUCs of this Chinese population. Male gender, sessile architecture, tumour location, tumour without multifocality, high histological grade and preoperative ipsilateral hydronephrosis were independent predictive factors for worse pathological outcome of UTUCs.

摘要

目的

分析中国某一全国性大容量中心的 729 例上尿路尿路上皮癌(UTUC)患者的临床病理数据,探讨其发生不良病理结果(肌层浸润性 pT2+、非器官局限性 pT3+或 N+和组织学 3 级)的预测因素。

方法

回顾性分析 2002 年 1 月至 2010 年 12 月期间在我院接受治疗的 729 例 UTUC 患者的临床病理资料,采用单因素和多因素 logistic 回归分析。

结果

女性患者(56.4%)多于男性,输尿管肿瘤(52.7%)多于肾盂肿瘤。多因素分析显示,男性(HR 1.898,P=0.001)、无蒂型(HR 3.249,P<0.001)、高级别(HR 5.007,P<0.001)、同侧肾积水(HR 4.768,P<0.001)、肾盂位置(HR 2.620,P<0.001)和肿瘤无多灶性(HR 1.639,P=0.028)是肌层浸润性 UTUC 的预测因素。男性(HR 2.132,P<0.001)、肾盂位置(HR 3.466,P<0.001)、肿瘤无多灶性(HR 2.532,P=0.001)、无蒂型肿瘤(HR 3.274,P<0.001)和高级别(HR 3.019,P<0.001)是肿瘤非器官局限性的预测因素。年龄较大(HR 1.047,P<0.001)、无蒂型肿瘤(HR 25.192,P<0.001)、同侧肾积水(HR 1.689,P=0.024)和尿细胞学阳性(HR 1.997,P=0.006)是组织学 3 级 UTUC 的预测因素。

结论

该中国人群 UTUC 患者以女性和输尿管肿瘤为主。男性、无蒂型、肿瘤位置、肿瘤无多灶性、高级别和术前同侧肾积水是 UTUC 不良病理结果的独立预测因素。

相似文献

1
Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.预测上尿路上皮癌不良病理结局的因素:来自中国一个全国性大容量中心的经验。
BJU Int. 2013 Nov;112(7):917-24. doi: 10.1111/bju.12238. Epub 2013 Jul 26.
2
Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.肾积水程度可预测上尿路高级别尿路上皮癌患者的不良病理特征和更差的肿瘤学结局。
Urol Oncol. 2014 Oct;32(7):981-8. doi: 10.1016/j.urolonc.2014.02.018. Epub 2014 Jul 9.
3
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.多机构验证术前积水在预测上尿路上皮癌高级别病理肿瘤分期中的能力。
Urol Oncol. 2013 Aug;31(6):904-8. doi: 10.1016/j.urolonc.2011.07.011. Epub 2011 Sep 9.
4
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中,肿瘤位置与多灶性的影响:无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.
5
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.性别相关差异在上尿路尿路上皮癌 I 期至 III 期患者中的表现:来自监测、流行病学和最终结果数据库的结果。
Urology. 2010 Feb;75(2):321-7. doi: 10.1016/j.urology.2009.09.048. Epub 2009 Dec 4.
6
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.Ki-67在上尿路高级别尿路上皮癌患者中预测价值的多机构验证
J Urol. 2015 May;193(5):1486-93. doi: 10.1016/j.juro.2014.11.007. Epub 2014 Nov 11.
7
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.肿瘤多灶性对接受根治性肾输尿管切除术治疗的患者结局的影响。
Eur Urol. 2012 Feb;61(2):245-53. doi: 10.1016/j.eururo.2011.09.017. Epub 2011 Sep 28.
8
Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.肾盂和输尿管移行细胞癌:台湾人群的比较人口统计学特征、病理分级和分期以及5年生存率
BJU Int. 2009 Feb;103(3):312-6. doi: 10.1111/j.1464-410X.2008.07985.x. Epub 2008 Sep 8.
9
Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.高级别上尿路尿路上皮癌患者中 Ki-67 作为独立预测肿瘤学结果的前瞻性分析。
J Urol. 2014 Jan;191(1):28-34. doi: 10.1016/j.juro.2013.07.012. Epub 2013 Jul 16.
10
Severity of hydronephrosis correlates with tumour invasiveness and urinary bladder recurrence of ureteric cancer.肾积水的严重程度与输尿管癌的肿瘤侵袭性和膀胱癌复发相关。
BJU Int. 2013 Aug;112(4):489-94. doi: 10.1111/bju.12157. Epub 2013 Jun 7.

引用本文的文献

1
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma.中国上尿路尿路上皮癌患者的基因组图谱与临床相关性
JCO Precis Oncol. 2025 Jul;9:e2500195. doi: 10.1200/PO-25-00195. Epub 2025 Jul 25.
2
Consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology on the management of muscle-invasive and advanced urothelial carcinoma.香港泌尿外科协会和香港泌尿肿瘤学会关于肌层浸润性和晚期尿路上皮癌管理的共识声明。
Front Oncol. 2025 May 8;15:1564487. doi: 10.3389/fonc.2025.1564487. eCollection 2025.
3
Distinct clinical features of urothelial carcinoma with low-expressing human epidermal growth factor receptor 2 status.
人表皮生长因子受体2低表达状态的尿路上皮癌的独特临床特征。
Transl Androl Urol. 2024 Nov 30;13(11):2419-2429. doi: 10.21037/tau-24-354. Epub 2024 Nov 28.
4
Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database.上尿路鳞状细胞癌:国家癌症数据库中的临床特征、治疗模式和生存结局。
World J Urol. 2024 Nov 26;42(1):647. doi: 10.1007/s00345-024-05362-x.
5
Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: a case report.转移性肾输尿管切除术后患者使用维迪西妥单抗(RC48)长期治疗方案:一例病例报告
Front Oncol. 2024 Sep 13;14:1419882. doi: 10.3389/fonc.2024.1419882. eCollection 2024.
6
Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing.利用单细胞测序技术研究上尿路尿路上皮癌和膀胱尿路上皮癌之间的细胞相似性和差异性。
Front Immunol. 2024 Jun 6;15:1298087. doi: 10.3389/fimmu.2024.1298087. eCollection 2024.
7
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.抗体药物偶联物(ADC)disitamab vedotin 在人表皮生长因子受体 2(HER2)阳性局部晚期或转移性尿路上皮癌患者中的疗效和安全性:两项 II 期临床试验的联合分析。
J Clin Oncol. 2024 Apr 20;42(12):1391-1402. doi: 10.1200/JCO.22.02912. Epub 2023 Nov 21.
8
Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.上尿路尿路上皮癌(UTUC)的诊断与风险分层:综述
Cancers (Basel). 2023 Oct 14;15(20):4987. doi: 10.3390/cancers15204987.
9
LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.基于液相色谱-质谱联用的尿液非靶向代谢组学分析以识别和细分尿路上皮癌。
Front Oncol. 2023 May 12;13:1160965. doi: 10.3389/fonc.2023.1160965. eCollection 2023.
10
Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes.经腹腔与经腹膜后腹腔镜肾输尿管全长切除术治疗上尿路上皮癌的围手术期和肿瘤学结局:系统评价和比较结局的汇总分析。
World J Surg Oncol. 2023 May 29;21(1):163. doi: 10.1186/s12957-023-03046-1.